Our findings provide new insights indicating that RPL24 expression levels increased after CDDP treatment, which was confirmed in human CC lines and human cervical tumor tissues, and high RPL24 expression was associated with a better prognosis, which was further verified in an in vivo mouse model, human cervical tumor tissues, and online databases. The gene discussed is RPL24; the disease is uterine cervix neoplasm.